Analysts reviewing ARIAD Pharmaceuticals, Inc. have recently updated their recommended buy/sell ratings and price targets on the stock. Ratings and price target breakdown: 01/11/2017 – ARIAD Pharmaceuticals, Inc. was downgraded …
Rhenman & Partners Asset Management Ab acquired 220,000 shares as Ariad Pharmaceuticals Inc (ARIA)'s stock 0.00%. The biopharmaceutical company reported ($1.27) earnings per share for the quarter, missing analysts' …
South Dakota Inv Council invested in 0.01% or 5,800 shares. (NASDAQ:ARIA) for 71,400 shares. Envestnet Asset Mngmt Incorporated invested in 646,953 shares or 0.03% of the stock. 14,082 are held by Legal General Group Inc Inc Public …
was indicted on July 20 for insider trading in the stock of Cambridge-based Ariad
Rhenman & Partners Asset Management Ab increased Ariad Pharmaceuticals Inc (ARIA ... the right direction as investors keep concentrating on superior returns from the stock market. With so much historical data available, investors may …
He’s also been a long-running producer of the ARIA annual awards and promoted …
one has given a hold rating and six have issued a buy rating to the stock. Rhenman & Partners Asset Management Ab increased Ariad Pharmaceuticals Inc (ARIA) stake by 32.59% reported in 2016Q4 SEC filing.
The stock of Diageo plc (ADR) (NYSE:DEO) has "Buy" rating given on Thursday, August 6 by Investec. (NASDAQ:ARIA) has "Underweight" rating given on Wednesday, May 11 by Barclays Capital. As per Monday, June 20, the company …
... Asset Management Ab increased Ariad Pharmaceuticals Inc (ARIA) stake by 32.59% reported in 2016Q4 SEC filing. The firm owned 78,821 shares of the …